Cite Filings / ACRV / 0001193125-22-286805
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B4

Prospectus

Acrivon Therapeutics, Inc. · Filed 2022-11-16 · Acc 0001193125-22-286805

Documents 1

  • 424B4 Prospectus , d383050d424b4.htm

Around this filing

  • 2022-11-16 4 Options or other derivatives
  • 2022-11-16 4 Options or other derivatives
  • 2022-11-16 4 Options or other derivatives
  • 2022-11-16 4 Chief Medical Officer acquired 20,030 shares (grant or award)
  • 2022-11-16 4 Chief Financial Officer acquired 20,030 shares (grant or award)
  • 2022-11-16 4 President and CEO acquired 1,524,947 shares (grant or award)
  • 2022-11-16 424B4 Prospectus

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d383050d424b4.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…